Open access
70
Views
14
CrossRef citations to date
0
Altmetric
Original Research
Patient preferences for reducing toxicities of treatments for gastrointestinal stromal tumor (GIST)
A Brett Hauber1 RTI Health Solutions, Research Triangle Park, NC, USACorrespondence[email protected]
, Juan Marcos Gonzalez1 RTI Health Solutions, Research Triangle Park, NC, USA
, John Coombs2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, Andres Sirulnik2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
, David Palacios2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
& Norman Scherzer3 The Life Raft Group, Wayne, NJ, USA
Pages 307-314
|
Published online: 24 Jun 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.